Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

Person › Details

John Dawson (Oxford BioMedica plc (LSE: OXB))

Dawson, John (Oxford BioMedica 200810– CEO before Cephalon Europe)

	Organisation	Oxford BioMedica plc (LSE: OXB)
	Group	Oxford BioMedica (Group)
	Former/major organisation	Cephalon Europe
	Today	Teva (Group)
	Group	Teva (Group)
	Product	TroVax®
	Product 2	ProSavin®

Record changed: 2019-06-09

More documents for John Dawson

[1] Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford....
[2] Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford....
[3] Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford....
[4] Oxford BioMedica plc. (11/23/18). "Press Release: Oxford BioMedica Announces New Digital Framework Initiative to Streamline the Production of Next-generation Medicines with Cash Injection from Innovate UK". Oxford....
[5] Boehringer Ingelheim. (8/6/18). "Press Release: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis". Ingelhei...
[6] Oxford BioMedica plc. (6/6/18). "Press Release: Oxford BioMedica and Axovant Sciences Enter into a $842.5 Million Exclusive Worldwide Licence Agreement for OXB-102 for the Treatment of Parkinson’s Disease". Oxford....
[7] Oxford BioMedica plc. (2/15/18). "Press Release: Oxford BioMedica Announces Collaboration and Licence Agreement with Bioverativ in the Field of Haemophilia Gene Therapy". Oxford....
[8] Oxford BioMedica plc. (9/4/17). "Press Release: Oxford BioMedica to Present at Rodman & Renshaw Annual Global Investment Conference, New York". Oxford....
[9] Oxford BioMedica plc. (8/17/17). "Press Release: Interim Results for the Six Months Ended 30 June 2017". Oxford....
[10] Oxford BioMedica plc. (8/11/17). "Press Release: Oxford BioMedica Announces a £2 Million Two-year Collaboration Co-funded by Innovate UK". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]